Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 307

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis

Open access
Zhong, Jie-Hui, Huang, Dan-Hui, Chen, Zi-Yu·2017·Oncotarget

Abstract

// Jie-Hui Zhong 1 , Dan-Hui Huang 1 and Zi-Yu Chen 1 1 Department of Clinical Medicine, The First Clinical Medical College, Southern Medical University, Guangzhou, 510515, China Correspondence to: Jie-Hui Zhong, email: zhongjiehui@126.com Keywords: systemic immune-inflammation index, solid tumors, meta-analysis Received: April 05, 2017 Accepted: June 10, 2017 Published: June 29, 2017 ABSTRACT Background: Inflammation may play an important role in cancer progression, and a higher systemic immune-inflammation index (SII) has been reported to be a poor prognostic marker in several malignancies. However, the results of published studies are inconsistent. Materials and Methods: A systematic review of databases was conducted to search for publications regarding the association between blood SII and clinical outcome in solid tumors with a date up to February 12, 2017. The primary outcome was overall survival (OS) and the secondary outcomes were progression-free survival (PFS) and cancer-specific survival (CSS). Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were used to assess the strength of the association between blood SII and clinical outcome in solid tumors. Results: A total of 15 articles were included in the analysis. Overall, systemic immune-inflammation index greater than the cutoff predicted poor overall survival (HR = 1.55, 95% CI = 1.27–1.88; P < 0.001). Subgroup analyses revealed that high systemic immune-inflammation index indicated a worse overall survival in hepatocellular carcinoma ( P < 0.001), urinary cancers ( P < 0.001), gastrointestinal tract cancers ( P = 0.02), small cell lung cancer ( P < 0.05) and acral melanoma ( P < 0.001). Hazard ratio for systemic immune-inflammation index greater than the cutoff for cancer-specific survival was 1.44 ( P < 0.05). Conclusions: Elevated systemic immune-inflammation index is associated with a worse overall survival in many solid tumors. The systemic-inflammation index can act as a powerful prognostic indicator of poor outcome in patients with solid tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.18856

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 307

Metadata

Authors
Zhong, J.-H., Huang, D.-H., & Chen, Z.-Y.
Venue
Oncotarget
Published
2017-06-29
Volume
8
Issue
43
Pages
75381-75388
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2730495368
Cited by
307
References
32
FWCI
1.88
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.18632/oncotarget.18856
The paper
Zhong, J.-H., Huang, D.-H., & Chen, Z.-Y. (2017). Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget. https://doi.org/10.18632/oncotarget.18856

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.